FindMyKOL
Clinical trialNCT01057121CompletedPhase 1/PHASE2Interventional

Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma

SponsorNational Cancer Institute (NCI)Enrollment38AIDS-Related Kaposi SarcomaRecurrent Kaposi Sarcoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This phase I/II trial studies the side effects and best dose of lenalidomide and to see how well it works in treating patients with acquired immunodeficiency syndrome (AIDS)-related Kaposi sarcoma (KS). Lenalidomide may stop the growth of tumor cells by blocking blood flow to the tumor.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Kelly Shimabukuro

    AIDS Associated Malignancies Clinical Trials Consortium

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ucla Center for Clinical Aids Research and Education

    Los Angeles, California, United States

  • University of California San Diego

    San Diego, California, United States

  • San Francisco General Hospital

    San Francisco, California, United States

  • University of Miami Miller School of Medicine-Sylvester Cancer Center

    Miami, Florida, United States

  • Cancer Center of Hawaii-Hawaii Aids Clinical Research Program

    Honolulu, Hawaii, United States

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital

    Baltimore, Maryland, United States

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

  • Memorial Sloan-Kettering Cancer Center

    New York, New York, United States

  • Ohio State University Comprehensive Cancer Center

    Columbus, Ohio, United States

  • Pennsylvania Oncology Hematology Associates

    Philadelphia, Pennsylvania, United States

  • Thomas Street Clinic

    Houston, Texas, United States

  • Harborview Medical Center

    Seattle, Washington, United States

  • Virginia Mason Medical Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
27 Aug 2010
Primary completion
4 Aug 2014
Completion
4 Aug 2014
Last update posted
8 Feb 2022
Registered enrollment
38
Registry id
NCT01057121

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.